Literature DB >> 24999596

Disease control in cutaneous leishmaniasis is independent of IL-22.

Sven Brosch1, Kirsten Dietze-Schwonberg1, Susanna Lopez Kostka1, Beate Lorenz1, Stefan Haak2, Burkhard Becher3, Esther von Stebut4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24999596     DOI： 10.1038/jid.2014.282

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

Review 1.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

2.  Genetic variation in Interleukin-32 influence the immune response against New World Leishmania species and susceptibility to American Tegumentary Leishmaniasis.

Authors:  Jéssica Cristina Dos Santos; Valéria Bernadete Leite Quixabeira; Muriel Vilela Teodoro Silva; Michelle S M A Damen; Kiki Schraa; Martin Jaeger; Marije Oosting; Samuel T Keating; Miriam Leandro Dorta; Sebastião Alves Pinto; Fernanda Bugalho Duarte; Ledice Inácia de Araújo Pereira; Mihai G Netea; Fátima Ribeiro-Dias; Leo A B Joosten
Journal:  PLoS Negl Trop Dis       Date:  2020-02-05

3.  Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to Leishmania infection.

Authors:  Bernard Ong'ondo Osero; Raphael Taiwo Aruleba; Frank Brombacher; Ramona Hurdayal
Journal:  Cytokine X       Date:  2020-12

Review 4.  A Critical Overview of Interleukin 32 in Leishmaniases.

Authors:  Fátima Ribeiro-Dias; Iara Barreto Neves Oliveira
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561

5.  IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis.

Authors:  Ciara Gimblet; Michael A Loesche; Lucas Carvalho; Edgar M Carvalho; Elizabeth A Grice; David Artis; Phillip Scott
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.